Novel therapy for children with chronic hormone deficiency provides lifeline for parents

Apr 12, 2019

  • Alkindi® is the first replacement therapy specially designed for infants, children and adolescents with paediatric adrenal insufficiency
  • Adrenal insufficiency is caused by a lack of the stress hormone cortisol – which can be fatal
  • This new therapy, which has been developed by University of Sheffield spin-out company Diurnal, has been granted market authorisation by the European Medicine Agency.

Read more

Recent Blog Posts

Family Meeting in Newry, Ireland – 9th February, 2-6pm

Family Meeting in Newry, Ireland – 9th February, 2-6pm

The annual Ireland family meeting will be held on Sunday, 9th February from 2pm - 6pm at Bessbrook Community Centre, Ireland. Places are limited so for more information and to book a place, please contact Jo & Mark - our area coordinators for Ireland - through the...

CAH treatment may be linked to lower bone mineral density

CAH treatment may be linked to lower bone mineral density

Higher glucocorticoid doses for adults with CAH may be associated with lower bone mineral density, especially among women and those prescribed prednisolone, according to findings published in Clinical Endocrinology. Read more on Healio. Recent Blog Posts